# Three Off-Patent Amino Acids Could Unlock the Next Generation of mRNA Therapies - Date: 2026-04-21 - Category: Biotech & Life Sciences Three common amino acids already manufactured at pharmaceutical scale boosted mRNA delivery 5- to 20-fold in mice, pushing liver failure survival from 33% to 100%. The catch: any LNP-based therapy could adopt the approach without a new drug filing. ---